Costing, Advocacy Strategies and Policy Transformation Jorge Romero Leon Accountability and Monitoring in Health Initiative Costing for Change Seminar.

Slides:



Advertisements
Similar presentations
Introduction to the Results Framework. What is a Results Framework? Graphic and narrative representation of a strategy for achieving a specific objective.
Advertisements

HEALTH PLANNING AND MANAGEMENT
From Research to Advocacy
Donald T. Simeon Caribbean Health Research Council
PEPFAR’s Approach to Maximize Efficiency, Effectiveness and Impact
Engaging Patients and Other Stakeholders in Clinical Research
Costing Health Interventions Teresa Guthrie Centre for Economic Governance and AIDS in Africa March 2007 Sources of slides: Health Economic Unit, UCT and.
Return On Investment Integrated Monitoring and Evaluation Framework.
Economic evaluation considers assessment of intervention effects in economic terms, which is often of greatest interest to fund allocators Intervention.
Comprehensive M&E Systems
RIGHT BASED APPROACH.
Community Level Models; Participatory Research and Challenges
Generating evidence for change: Implementing the post-ICIUM research agenda Dennis Ross-Degnan, ScD Harvard Medical School and Harvard Pilgrim Health Care.
STRENGTHENING HEALTH SYSTEMS Anne Mills DCPP Editor London School of Hygiene and Tropical Medicine.
Module 5 Emergencies and the Health Systems. Module 5 Hospital System Health System Epidemiology and Surveillance Prevention and Control of Communicable.
Eric R. Johnson Hillsborough County, (Tampa) FL
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
IPhVWP Polish Presidency, Warsaw October 6 th 2011 Almath Spooner Irish Medicines Board Monitoring the outcome of risk minimisation activities.
Teresa Guthrie M.PH (Health Economics) HIV modelling for in-country ownership solutions – generation of evidence IAS Conference, Washington DC, July.
Essential Service # 7:. Why learn about the 10 Essential Services?  Improve quality and performance.  Achieve better outcomes – improved health, less.
Achutha Menon Centre for Health Science Studies Sree Chitra Tirunal Institute for Medical Sciences and Technology.
1 Module 4: Designing Performance Indicators for Environmental Compliance and Enforcement Programs.
Setting Priorities Delivering Best Value Managing Scarcity: Experience from Tayside Danny Ruta.
Abu Raihan, MD, MPH Director of Program, Asia IAPB 9th GA, Hyderabad, September 2012 Symposium 6: Challenges in Monitoring.
HSA 171 CAR. 1436/ 7/4  The results of activities of an organization or investment over a given period of time.  Organizational Performance: ◦ A measure.
My Own Health Report: Case Study for Pragmatic Research Marcia Ory Texas A&M Health Science Center Presentation at: CPRRN Annual Grantee Meeting October.
INTERNATIONAL SOCIETY FOR TECHNOLOGY IN EDUCATION working together to improve education with technology Using Evidence for Educational Technology Success.
CONNECTICUT HEALTH FOUNDATION: Update on Evaluation Planning for the Strategic Plan.
Introduction to MAST Kristian Kidholm Odense University Hospital, Denmark.
Summary of ICIUM Chronic Care Track Prepared by: Ricardo Perez-Cuevas Veronika Wirtz David Beran.
Transforming Community Services Commissioning Information for Community Services Stakeholder Workshop 14 October 2009 Coleen Milligan – Project Manager.
Guidance notes on the Intevention Logic and on Building a priority axis 27 September 2013.
Commissioning Self Analysis and Planning Exercise activity sheets.
State HIE Program Chris Muir Program Manager for Western/Mid-western States.
Crosswalk of Public Health Accreditation and the Public Health Code of Ethics Highlighted items relate to the Water Supply case studied discussed in the.
Institut Català d’Oncologia ICO DiR. The ‘Qualy’ End of Life Care Observatory - WHO Collaborating Centre for Public Health Palliative Care Programmes Central.
More than just reinventing the wheel … Evidence review: Linking SRH and HIV Alejandra Trossero Senior HIV Officer: Linking SRH and HIV.
EDPQS in 10 minutes: Overview of European Drug Prevention Quality Standards (EDPQS) With financial support from the Drug Prevention and Information Programme.
April_2010 Partnering initiatives at country level Proposed partnering process to build a national stop tuberculosis (TB) partnership.
SOCIAL BUSINESS PLAN. SOCIAL BUSINESS  Social enterprise is a business that trades for a social purpose. The social aims of the business are of equal.
21/4/2008 Evaluation of control measures 1. 21/4/2008 Evaluation of control measures 2 Family and Community Medicine Department.
IAS Policy and Advocacy priority on Treatment as Prevention Carlos F. Cáceres Multidisciplinary Research on ARV-based Prevention 30 June 2013 Kuala Lumpur.
THE EVIDENCE SANDWICH MODEL Dr. Soumyadeep Bhaumik BioMedical Genomics Centre, Kolkata Research priority setting exercises:
1 Pharmaceutical System Strengthening: Is There a Need for a New Paradigm? Douglas Keene, PharmD, MHS ICIUM-3 Pre-Conference Session 14 November 2011.
Human rights and applied budget work Current trends, gap analysis, costing and related advocacy strategies Jorge Romero Leon Accountability and Monitoring.
Revisions Proposed to the CIS Plan by the Global Office Misha V. Belkindas Budapest, July 3-4, 2013.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
05_XXX_MM1 Introducing Medical Abortion: Thinking Strategically Peter Fajans MD MPH and Ronnie Johnson PhD UNDP/UNFPA/WHO World Bank Special Programme.
Mt. Hood. IOM Report: 10 Years After & More Coming Mitch Greenlick, Ph.D. Oregon State Representative April 21, 2010.
Department of Health Service Research Head: Prof. Dr. Ansgar Gerhardus Interactive session: Presentation of the INTEGRATE-HTA Model and short discussion.
Identifying, Evaluating and Prioritising Urban Adaptation Measures.
International Land Coalition Advancing the Monitoring of Land Governance for Ensuring Impact on Poverty Reduction Annalisa Mauro.
Implementation Science: Finding Common Ground and Perspectives Laura Reichenbach, Evidence Project, Population Council International Conference on Family.
Maternal Care Quality Standards in the South African Context Workshop: Pretoria Villa Sterne 6 th April 2016 Karen Hofman PRICELESS SA, Wits School of.
Comparative Effectiveness Research (CER) and Patient- Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy.
Presentation to the Health Portfolio Committee Presentation to Health Portfolio Committee Free State Department of Health 15 APRIL 2003.
Burden of Disease Research Unit (BOD) Towards a National Procedure Coding Standard for South Africa Lyn Hanmer Health Informatics R&D Co-ordination (HIRD)
Quality Improvement An Introduction
Care Act and young people with Sensory Impairments
Presentation Developed for the Academy of Managed Care Pharmacy
PEFA 2016 Slides selected from the training materials of the PEFA secretariat.
MHA 620 Competitive Success/snaptutorial.com
MHA 620 Education for Service-- snaptutorial.com.
MHA 620 Teaching Effectively-- snaptutorial.com
Presentation Developed for the Academy of Managed Care Pharmacy
PEFA 2016 Slides selected from the training materials of the PEFA secretariat.
Dr Peter Groves MD FRCP Consultant Cardiologist
DG Employment, Social Affairs and Inclusion
Tracie Wills Senior Commissioning Officer
Presentation Developed for the Academy of Managed Care Pharmacy
Presentation transcript:

Costing, Advocacy Strategies and Policy Transformation Jorge Romero Leon Accountability and Monitoring in Health Initiative Costing for Change Seminar Poiana - Brasov, Romania October 27th, 2011

Contents Transforming the model of care Elements of the transformation What is effective advocacy? Where does costing fit in? Costing and budgeting What is costing useful for? Costing definitions (minimal) Perspective of costing Information sources Not rocket science, but…

Transformation of the model of care Status quo Limited access model of care, high cost, ineffective, limited access to pain relief, no national strategy and limited training Costing more effective, identifies GAPS Education, discussion of alternative models, changes in legislation to introduce access to essential medicines Policy changes, adoption of standards, adoption of variety of models; training and implementation of new policies Budget monitoring, cost comparison, auditing of implemented standards; costing of new activities Transformation and institutional adoption of new model of care Gradual implementation of effective, inclusive model of care with in-patient services, home and community care, increased coverage and exhaustive training Monitoring of allocation for advanced implementation, trend analysis and program auditing

Elements of the transformation Multiple transformations Of the legislation Of the institutional support for palliative care Of the model of care Of the budgetary allocations for supporting humane and up to standard policy alternatives Of the quality, reach and inclusion of services to the broadest possible number of affected persons

Elements of the transformation The transformation takes many years It requires standards, justification, evidence of feasible policy alternatives and leadership to engage different levels of stakeholders and decision makers. It requires increasingly effective advocacy and broad network support. The Public Health Program of the Open Society Foundations has a diverse strategy that considers a wealth of elements to promote transformation from below, from above, and through alliances.

What is effective advocacy? It identifies and addresses gaps. It identifies policy programs and activities that could address those gaps. It complements international standards and advocacy strategies with context specific activities. It engages stakeholders at every stage to inform strategy, to develop methodological choices and forge alliances to ‘shake’ things up, to ‘move’ towards the adoption of alternatives and ‘drive’ legal and institutional changes.

What is effective advocacy? It develops Knowledge Existing gaps Models of care and international standards Requirements for implementation under local constraints and in the local system Evidence Of existing systemic constraints Of viable alternatives Feasibility of policy choices and institutional support at different stages

What is effective advocacy? Justification On the basis of human cost and lagging conditions for development On the basis of Human Rights obligations On the basis of the legal and financial feasibility of transformation (identifies alternatives within reach) On the basis of analysis warranting cost-effectiveness of up to standard policies

What is effective advocacy? Finally, effective advocacy seeks to impact decision- makers to persuade, compel or coerce. It maps interests, power, allies, plausible support and instances of opposition. It develops proactive, not reactive strategies. It develops leverage.

Transformation of the model of care Status quo Limited access model of care, high cost, ineffective, limited access to pain relief, no national strategy and limited training Costing more effective, identifies GAPS Education, discussion of alternative models, changes in legislation to introduce access to essential medicines Policy changes, adoption of standards, adoption of variety of models; training and implementation of new policies Budget monitoring, cost comparison, auditing of implemented standards; costing of new activities Transformation and institutional adoption of new model of care Gradual implementation of effective, inclusive model of care with in-patient services, home and community care, increased coverage and exhaustive training Monitoring of allocation for advanced implementation, trend analysis and program auditing

Transformation of the model of care Status quo Limited access model of care, high cost, ineffective, limited access to pain relief, no national strategy and limited training Costing more effective, identifies GAPS Education, discussion of alternative models, changes in legislation to introduce access to essential medicines Policy changes, adoption of standards, adoption of variety of models; training and implementation of new policies Budget monitoring, cost comparison, auditing of implemented standards; costing of new activities Transformation and institutional adoption of new model of care Gradual implementation of effective, inclusive model of care with in-patient services, home and community care, increased coverage and exhaustive training Monitoring of allocation for advanced implementation, trend analysis and program auditing International standards and support Policy alternatives (drug policy, models of care, public financing of palliative care) Drug availability Education, mentoring, professional training, popular education and communication / dissemination strategies

Transformation of the model of care Status quo Limited access model of care, high cost, ineffective, limited access to pain relief, no national strategy and limited training Costing more effective, identifies GAPS Education, discussion of alternative models, changes in legislation to introduce access to essential medicines Policy changes, adoption of standards, adoption of variety of models; training and implementation of new policies Budget monitoring, cost comparison, auditing of implemented standards; costing of new activities Transformation and institutional adoption of new model of care Gradual implementation of effective, inclusive model of care with in-patient services, home and community care, increased coverage and exhaustive training Monitoring of allocation for advanced implementation, trend analysis and program auditing International standards and support Policy alternatives (drug policy, models of care, public financing of palliative care) Drug availability Education, mentoring, professional training, popular education and communication / dissemination strategies

Transformation of the model of care Status quo Limited access model of care, high cost, ineffective, limited access to pain relief, no national strategy and limited training Costing more effective, identifies GAPS Education, discussion of alternative models, changes in legislation to introduce access to essential medicines Policy changes, adoption of standards, adoption of variety of models; training and implementation of new policies Budget monitoring, cost comparison, auditing of implemented standards; costing of new activities Transformation and institutional adoption of new model of care Gradual implementation of effective, inclusive model of care with in-patient services, home and community care, increased coverage and exhaustive training Monitoring of allocation for advanced implementation, trend analysis and program auditing International standards and support Policy alternatives (drug policy, models of care, public financing of palliative care) Drug availability Education, mentoring, professional training, popular education and communication / dissemination strategies

Transformation of the model of care Status quo Limited access model of care, high cost, ineffective, limited access to pain relief, no national strategy and limited training Costing more effective, identifies GAPS Education, discussion of alternative models, changes in legislation to introduce access to essential medicines Policy changes, adoption of standards, adoption of variety of models; training and implementation of new policies Budget monitoring, cost comparison, auditing of implemented standards; costing of new activities Transformation and institutional adoption of new model of care Gradual implementation of effective, inclusive model of care with in-patient services, home and community care, increased coverage and exhaustive training Monitoring of allocation for advanced implementation, trend analysis and program auditing International standards and support Policy alternatives (drug policy, models of care, public financing of palliative care) Drug availability Education, mentoring, professional training, popular education and communication / dissemination strategies

Costing and Budgeting Costing - determining the expenditure required to purchase the resources needed to achieve an activity or strategy. Budgeting - the allocation of resources to match requirements. Once the cost of an activity is determined, the total number of desired activities will then determine the desired funding. The number of activities will be adjusted to fit the amount of funds allocated, which will become the budget. Adapted from Guthrie, Teresa. Costing Health Interventions. CEGAA, South Africa, 2007.

What is costing useful for? Identifying a human rights gap in policy, e.g. lack of access, inadequacy of care, failure to meet essential standard or minimum core obligations Assessing efficiency in two “equivalent” programs -which one yields the greatest benefit with a given amount of resources? Identifying important cost issues for potential savings Strategic planning and budgeting for programs Together, costing and budgeting helps the planning process by ensuring that the goals are financially affordable. Adapted from Guthrie, Teresa. Costing Health Interventions. CEGAA, South Africa, 2007.

Costing definitions In costing we identify and measure all the inputs and all the outputs. Costs are always related to the outcomes they produce. Outcomes can also be called benefits or output. There are intermediate and final outcomes. Some examples: HIV treatment programmes: cost per life year gained HIV prevention programmes: cost per HIV case prevented Immunisations: cost per Fully Immunised Child (FIC) Immunisations: cost per measles case prevented/death prevented Palliative care: Cost per patient per day in inpatient units Palliative care: Cost per outpatient visit At a very basic level, we often relate costs to certain activities, such as the cost of an inpatient day or the cost per outpatient visit Adapted from Guthrie, Teresa. Costing Health Interventions. CEGAA, South Africa, 2007.

Perspective of costing From whose point of view is the costing being undertaken? Societal Perspective (the patient and the health system and any other relevant individuals); also known as societal costs Health-system Perspective (the health system only); also known as provider costs or health system costs Patient Perspective (the patient only or the patient and her caregiver); also known as patient or consumer costs The perspective will determine which costs are to be included and will affect the methodology Adapted from Guthrie, Teresa. Costing Health Interventions. CEGAA, South Africa, 2007.

Information sources Literature review of published reports Expert opinion (Delphi panel) Data bases Prospective collection of the data Medical records Information of prices from the market Unit costs of as many ingredients as possible Programme budgets and expenditure records Clinical trials which provide outcomes Adapted from Guthrie, Teresa. Costing Health Interventions. CEGAA, South Africa, 2007.

Costing is not rocket science While we will see very sofisticated costing exercises, even the most basic exercises have succeded: Cost of HIV treatment Cost of emergency maternal care Cost of immunization in marginalized communities The onus of responsibility for addressing a human right violation or policy gap lies on the State. Basic costing can be enough to identify the gap, propose a feasible alternative and ‘get the ball rolling’.

Costing is not rocket science Every costing exercise is context depending, despite flexible methodologies available, due to information constraints, systemic characteristics of care and context specific environmental factors that will affect the costs for provision of services. Every costing exercise will be difficult. While it will never be ‘bullet proof’, it must be sound, warranted, fully justified and externally validated to have traction.